Inhibition and deficiency of the immunoproteasome subunit LMP7 attenuates LCMV-induced meningitis.
-
Mundt S
Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
-
Engelhardt B
Theodor Kocher Institute, University of Bern, Bern, Switzerland.
-
Kirk CJ
Onyx Pharmaceuticals, South San Francisco, CA, USA.
-
Groettrup M
Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
-
Basler M
Division of Immunology, Department of Biology, University of Konstanz, Konstanz, Germany.
Published in:
- European journal of immunology. - 2016
English
In addition to antigen processing, immunoproteasomes were recently shown to exert functions influencing cytokine production by monocytes and T cells, T-helper cell differentiation, and T-cell survival. Moreover, selective inhibition of the immunoproteasome subunit LMP7 ameliorated symptoms of autoimmune diseases including CD4(+) T-cell mediated EAE. In this study, we show that LMP7 also plays a crucial role in the pathogenesis of lymphocytic choriomeningitis virus (LCMV)-induced meningitis mediated by CTLs. Mice lacking functional LMP7 display delayed and reduced clinical signs of disease accompanied by a strongly decreased inflammatory infiltration into the brain. Interestingly, we found that selective inhibition and genetic deficiency of LMP7 affect the pathogenesis of LCMV-induced meningitis in a distinct manner. Our findings support the important role of LMP7 in inflammatory disorders and suggest immunoproteasome inhibition as a novel strategy against inflammation-induced neuropathology in the CNS.
-
Language
-
-
Open access status
-
bronze
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/33717
Statistics
Document views: 34
File downloads: